Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BYFermentation

Regulatory Challenges for the International Commercialization of Fermented Functional Foods Containing Probiotics

6 affiliations
  1. 1Instituto de Ciencias Económico Administrativas, Área Académica de Comercio Exterior, Universidad Autónoma del Estado de Hidalgo, Circuito Ex Hacienda La Concepción S/N, San Juan Tilcuautla 42160, Mexico
  2. 2Instituto de Ciencias Básicas e Ingeniería, Área Académica de Química, Universidad Autónoma del Estado de Hidalgo, Carr. Pachuca-Tulancingo km. 4.5, Pachuca 42184, Mexico
  3. 3Tecnológico Nacional de México, Instituto Tecnológico de Celaya, Antonio García Cubas Pte #600, esq. Av. Tecnológico, A. P. 57, Celaya 38010, Mexico
  4. 4Instituto de Ciencias Económico Administrativas, Área Académica de Gastronomía y Turismo, Universidad Autónoma del Estado de Hidalgo, Circuito Ex Hacienda La Concepción S/N, San Juan Tilcuautla 42160, Mexico
  5. 5Departamento de Ingeniería Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala S/N, Santo Tomás, Ciudad de México 11340, Mexico
  6. 6Departamento de Biotecnología, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana Unidad Iztapalapa, Avenida San Rafael Atlixco 186, Iztapalapa, Ciudad de México 09340, Mexico

Abstract

The global market for fermented functional foods containing probiotics has expanded rapidly, driven by increasing consumer interest in health-oriented food products. However, despite their long history and recognized benefits, the international commercialization of these products is hindered by heterogeneous regulatory frameworks. This review examines the current global regulatory landscape governing probiotic fermented foods, with particular emphasis on key regions, including the United States, the European Union, Asia, Africa, Oceania, and Latin America. Differences in product classification, safety assessment, the permitted use of the term “probiotic”, and scientific substantiation requirements for health claims are discussed. Additionally, major regulatory barriers affecting international trade are analyzed, including non-tariff barriers, labeling restrictions, and variability in sanitary registration and approval processes. These challenges are further compounded by inconsistencies in evaluation methodologies and the lack of harmonized criteria for microbial characterization and functional validation. Together, these factors limit product standardization, increase development costs, and hinder innovation and market access, particularly for emerging probiotic strains. This review highlights the need for greater international harmonization and for integrating robust scientific evidence into regulatory frameworks to facilitate global trade while ensuring consumer safety and claimed product functionality.

Related

  1. International Regulatory Classification of Minimally Manipulated and Borderline Cell and Tissue Products: Implications for Mesenchymal Stromal Cell-Based Interventions
    Airat Bilyalov, Nikita Filatov, Natalia Iashina +9
    Bioengineering (Basel, Switzerland)Peer-reviewedCC BYFull textEurope PMC
  2. Dynamic three-dimensional chromatin remodeling in lung disease: mechanistic principles, pathogenic regulatory networks, and translational challenges
    Tiantian Liu, Songshan Jiang, Jing Wang +1
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  3. Challenges and opportunities with adapting international health care quality indicators to local contexts: a descriptive case study
    Isabelle Vedel, Deniz Cetin-Sahin, Geneviève Arsenault-Lapierre +3
    International Journal for Quality in Health CarePeer-reviewedCC BY-NC-ND 4.0Full textPMC
  4. Legal challenges and regulatory responses in online medical consultation
    Qi Chen
    Frontiers in Digital HealthPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  5. Novel Streptococcus mitis subsp. mitis Picklauza buccal isolate from individual with idiopathic pulmonary fibrosis containing functional mobile qacG Gene.
    S. N. Klauza, S. M. P. Pickelner, K. Spurgeon +7
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
BibTeX
@article{olverarosales2026regulatory,
  title = {{Regulatory Challenges for the International Commercialization of Fermented Functional Foods Containing Probiotics}},
  author = {Diana Karina Olvera-Rosales and Jesús Guadalupe Pérez‐Flores and Luis Guillermo González-Olivares and Juan Ramírez Godínez and Ilse Monroy-Rodríguez and Raúl Eduardo López-Hernández and Lizet Manzo-Martínez and María Aline Manzo and Laura Berenice Olvera-Rosales and Emmanuel Pérez-Escalante},
  journal = {Fermentation},
  year = {2026},
  month = jun,
  doi = {10.3390/fermentation12060274},
  url = {https://doi.org/10.3390/fermentation12060274},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Regulatory Challenges for the International Commercialization of Fermented Functional Foods Containing Probiotics
AU  - Diana Karina Olvera-Rosales
AU  - Jesús Guadalupe Pérez‐Flores
AU  - Luis Guillermo González-Olivares
AU  - Juan Ramírez Godínez
AU  - Ilse Monroy-Rodríguez
AU  - Raúl Eduardo López-Hernández
AU  - Lizet Manzo-Martínez
AU  - María Aline Manzo
AU  - Laura Berenice Olvera-Rosales
AU  - Emmanuel Pérez-Escalante
PY  - 2026
DA  - 2026/06/05
JO  - Fermentation
DO  - 10.3390/fermentation12060274
UR  - https://doi.org/10.3390/fermentation12060274
AB  - The global market for fermented functional foods containing probiotics has expanded rapidly, driven by increasing consumer interest in health-oriented food products. However, despite their long history and recognized benefits, the international commercialization of these products is hindered by heterogeneous regulatory frameworks. This review examines the current global regulatory landscape governing probiotic fermented foods, with particular emphasis on key regions, including the United States, the European Union, Asia, Africa, Oceania, and Latin America. Differences in product classification, safety assessment, the permitted use of the term “probiotic”, and scientific substantiation requirements for health claims are discussed. Additionally, major regulatory barriers affecting international trade are analyzed, including non-tariff barriers, labeling restrictions, and variability in sanitary registration and approval processes. These challenges are further compounded by inconsistencies in evaluation methodologies and the lack of harmonized criteria for microbial characterization and functional validation. Together, these factors limit product standardization, increase development costs, and hinder innovation and market access, particularly for emerging probiotic strains. This review highlights the need for greater international harmonization and for integrating robust scientific evidence into regulatory frameworks to facilitate global trade while ensuring consumer safety and claimed product functionality.
SN  - 2311-5637
ER  -